Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A

Cancer Genetics and Cytogenetics

Volumn 89, Issue 1, 1996, Pages 14-20

  Herrmann, Marille E ^a,b,c  

^a STONY BROOK UNIVERSITY   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HYBRID PROTEIN; PROTEIN TYROSINE KINASE;

AGED; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CASE REPORT; CONTROLLED STUDY; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; ONCOGENE; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

EID: 0030199827     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(95)00317-7     Document Type: Article

References (50)

1. 1. Williams ED (1979): The aetiology of thyroid tumors. Clin Endocrinol Metab 8:193-207.
2. 2. Schneider A (1990): Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am 19:495-507.
3. 3. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama N (1993): In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53:2940-2943.
4. 4. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G (1987): A new oncogene in human thyroid papillary carcinomas and their lymph nodal metastases. Nature 328:170-172.
5. 5. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A, Vecchio G, Della Porta G (1989): High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4:1457-1462.
6. 6. Santoro M, Carlomagno F, Hay ID, Herrmann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, Fusco A (1992): Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522.
7. 7. Santoro M, Sabino N, Ishizaka Y, Ushijama T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C, Fabien N, Sugimura T, Fusco A, Nagao M (1993): Involvement of ret oncogene in human tumours: Specificity of RET activation to thyroid tumours. Br J Cancer 68:460-464.
8. 8. Wajjwalku W, Nakamura S, Hasegawa Y, Miyazaki K, Satoh Y, Funahashi H, Matsuyama M, Takahashi M (1992): Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Jpn J Cancer Res 83:671-675.
9. TPC) in papillary thyroid carcinoma from Saudi Arabia. Cancer 73:176-180.
10. TPC oncogene product in cytoplasm. Oncogene 7:1441-1444.
11. 11. Lanzi C, Borello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G, Pierotti MA (1992): Identification of the product of two rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas. Oncogene 7:2189-2194.
12. 12. Takahashi M (1994): Ret proto-oncogene and human diseases. Int J Oncol 4:81-84.
13. 13. Leibovitz A (1986): Development of tumor cell lines. Cancer Genet Cytogenet 19:11-19.
14. 14. Herrmann Me, Talpos GB, Mohamed AN, Saxe A, Ratner S, Lalley PA, Wolman SR (1991): Genetic markers in thyroid tumors. Surgery 110:941-948.
15. 15. Sambrook J, Fritsch EF and Maniatis T (1989): Molecular cloning - A laboratory manual, Cold Spring Harbor Press.
16. 16. Blin N, Stafford DW (1976): A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303-2308.
17. 17. Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM, Vecchio G (1994): Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9:2531-2535.
18. 18. Feinberg A, Vogelstein B (1984): Addendum: A technique for radiolabeling DNA restriction fragments to a high specific activity. Anal Biochem 37:66-67.
19. 19. Grieco M, Santoro , Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A, Vecchio G (1990): PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563.
20. 20. Estour B, Van Herle AJ, Juillard GFJ, Totanes TL, Sparkes RS, Giuliano AE (1989): Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch [B] 57:167-174.
21. 21. Demeure MJ, Damsky CH, Elfman F, Goretzki PE, Wong MG, Clark OH (1992): Invasion by cultured human follicular thyroid cancer correlates with increased β1 integrin and production of proteases. World J Surg 16:770-776.
22. 22. Ishizaka Y, Itoh F, Tahira T, Ikeda I, Ogura T, Sugimura T, Nagao M (1989): Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line. Jpn J Cancer Res 80:1149-1152.
23. 23. Antonini P, Linares G, Gaillard N, Venuat AM, Schlumberger M, Travagli JP, Caillou B, Berger R, Parmentier C (1993): Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66). Cancer Genet Cytogenet 67:117-122.
24. 24. Fabien N, Fusco A, Santoro M, Barbier Y, Dubois P-M, Paulin C (1994): Description of human thyroid carcinoma cell line. Cancer 73:2206-2212.
25. 25. Leong SS, Horoszewicz JS, Shimaoka K, Friedman M, Kawinski E, Song MJ, Zeigel R, Chu TM, Baylin S, Mirand EA (1981): A new cell line for study of human medullary thyroid carcinoma. In: Advances in thyroid neoplasia. M Andreaoli, F Monaco, J Robbins (eds.) Field Educational Italia, Roma pp 95-108.
26. 26. Pfragner R, Höfler H, Behmel A, Ingolic E, Walser V (1990): Establishment and characterization of continuous cell line MTC-SK derived from human medullary thyroid carcinoma. Cancer Res 50:4160-4166.
27. 27. Cote GJ, Gagel RF (1987): Different mechanisms of calcitonin, calcitonin gene-related peptide and somatostatin regulation by glucocorticoids in a cell culture of human medullary thyroid carcinoma. Henry Ford Hosp Med J 35:149-152.
28. 28. Nelkin BD, Chen KY, de Bustros A, Roos BA, Baylin SB (1989): Changes in calcitonin gene RNA processing during growth of a human medullary thyroid carcinoma cell line. Cancer Res 49:6949-6952.
29. 29. Nelkin BD, Borges M, Mabry M, Baylin SB (1990): Transcription factor levels in medullary thyroid carcinoma cells differentiated by harvey ras oncogene: c-jun is increased. Biochem Biophys Res Commun 170:140-146.
30. 30. Yang K-P, Liang Y-F, Samaan NA (1991): Intrinsic drug resistance in human medullary thyroid carcinoma cell line: Association with overexpression of mdr1 gene and low proliferation fraction. Anticancer Res 11:1065-1068.
31. 31. de Bustros A, Ball DW, Peters R, Compton D, Nelkin BD (1992): Regulation of human calcitonin gene transcription by cyclic AMP. Biochem Biophys Res Commun 189:1157-1164.
32. 32. Ball DW, Azzoli CG, Baylin SB, Chi D, Dou S, Donis-Keller H, Cumaraswamy A, Borges M, Nelkin BD (1993): Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci USA 90:5648-5652.
33. 33. Ishizaka Y, Ushijima T, Sugimura T, Nagao M (1990): cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line. Biochem Biopys Res Commun 168:402-408.
34. 34. Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Goellner JR, Dewald GW (1990): Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 66:1213-1220.
35. 35. Herrmann MA, Hay ID, Bartelt DH, Ritland SR, Dahl RJ, Grant CS, Jenkins RB (1991): Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest 88:1596-1604.
36. 36. Herrmann ME, Mohamed A, Talpos G, Wolman SR (1991): Cytogenetic study of a papillary thyroid cancer with rearranged chromosome 10. Cancer Genet Cytogenet 57:209-217.
37. 37. Pierotti MA, Santoro M, Jenkins R, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Herrmann MA, Fusco A, Hay ID, Della Porta G, Vecchio G (1992): Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/ PTC, Proc Natl Sci Acad USA 89:1616-1620.
38. PTC oncogene in human thyroid cancer. Oncogene 7:1331-1337.
39. 39. Herrmann ME, Talpos GB, Wolman SR, Macoska J, Lalley PA (1993): Genetic markers in thyroid tumors [letter]. Surgery 113:596-598.
40. 40. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P, Wells SA Jr. (1993): Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856.
41. 41. Mulligan LM, Kwok JB, Healy CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JJK, Pap L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ (1993): Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
42. 42. Eng C, Smith DP, Mulligan LM, Nagai MA, Healy CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A, Ponder BAJ (1994): Point mutation within the tyrosine kinase domain of RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 3:237-241.
43. 43. Bongarzone I, Monzini N, Borrello G, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA (1993): Molecular characterization of a thyroid tumor-specific transforming sequence formed by a fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol Cell Biol 13:358-366.
44. 44. Bongarzone I, Butti Mg, Coronelli S, Borello MG, Santoro M, Mondellini P, Pilotti S, Fusco A, Della Porta G, Pierotti MA (1994): Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 54:2979-2985.
45. 45. Jhiang SM, Smanik PA, Mazzaferri EL (1994): Development of single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma. Cancer Lett 78:69-76.
46. 46. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A (1994): Molecular characterization of RET/PTC3; a novel rearranged version of the ret proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9:509-516.
47. 47. Jhiang SM, Mazzaferri EL (1994): The ret/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med 123:331-337.
48. 48. Herrmann ME, Lane MA, Talpos GB, Baunoch D, Lauf N, Ratner R, Lalley PA (1994): Molecular and cytogenetic alterations in 5 new thyroid cancer cell lines. Proceedings AACR 35:584.
49. 49. Herrmann ME, Talpos GB, Rydstedt LL, Meese E, Lang C, Abumrad N, Lalley PA (1995): Double minutes in the human papillary thyroid cancer cell line PTC-1113A. Cancer Genet Cytogenet (in press).
50. 50. Santoro M, Melillo RM, Grieco M, Berlingieri MT, Vecchio G, Fusco A (1993): The trk and ret tyrosine kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ 4:77-84.